Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review
- 1 November 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (11) , 659-666
- https://doi.org/10.1016/s1470-2045(01)00555-1
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Incidence of lung cancer in Denmark: historical and actual statusLung Cancer, 2000
- Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Improvement of Non-Small-Cell Lung Cancer Staging by Means of Positron Emission TomographyThe Thoracic and Cardiovascular Surgeon, 1999
- Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomographyEuropean Journal of Cardio-Thoracic Surgery, 1997
- Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997
- Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancerEuropean Respiratory Journal, 1996
- Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995
- Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucoseThe Annals of Thoracic Surgery, 1994